NPCE
Neuropace Inc
14.10$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 84.6% | 86.1% | 85.2% | 85.0% | 85.8% | 85.9% | 88.5% | 88.3% | 88.9% | 89.1% | 87.9% | 88.9% | |
| 9.8% | 16.8% | 13.1% | 13.6% | 16.0% | 14.2% | 24.5% | 21.5% | 19.3% | 20.5% | 14.9% | 12.9% | |
| 61.8% | 61.7% | 59.6% | 58.8% | 59.0% | 55.7% | 60.1% | 58.6% | 56.0% | 57.8% | 54.6% | 53.3% | |
| 11.4% | 11.4% | 11.8% | 11.9% | 12.0% | 13.6% | 14.0% | 12.8% | 13.9% | 13.9% | 15.0% | 15.4% | |
| 9.8% | 10.4% | 11.5% | 12.0% | 12.5% | 14.1% | 12.3% | 15.4% | 16.9% | 16.0% | 16.9% | 18.7% | |
| 83.5% | 80.8% | 85.5% | 89.5% | 89.8% | 91.5% | 78.0% | 81.7% | 82.7% | 82.0% | 85.4% | 87.7% | |
| 12.9% | 15.1% | 13.3% | 13.3% | 15.3% | 16.0% | 13.3% | 16.2% | 18.3% | 16.9% | 16.3% | 18.0% | |
| 1.6% | 1.5% | 1.7% | 1.8% | 1.9% | 2.0% | 1.7% | 1.9% | 1.9% | 2.0% | 2.2% | 2.3% | |
| 1.2% | 2.2% | 3.3% | 2.4% | 2.2% | 3.1% | 3.7% | 4.4% | 4.3% | 2.1% | 4.6% | 4.3% | |
| 56.3% | 52.9% | 58.7% | 62.5% | 61.5% | 62.9% | 54.3% | 55.2% | 54.8% | 55.8% | 59.7% | 60.8% | |
| 16.5% | 19.2% | 14.5% | 10.5% | 10.2% | 8.5% | 22.0% | 18.3% | 17.3% | 18.0% | 14.6% | 12.3% | |
| -501.1% | -468.0% | -518.7% | -551.2% | -545.9% | -561.0% | -487.8% | -514.7% | -512.5% | -523.3% | -565.3% | -582.8% | |
| 26.2% | 24.1% | 28.6% | 30.6% | 30.6% | 31.6% | 28.6% | 31.0% | 30.9% | 31.0% | 34.1% | 35.2% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.